Unrelated toxin-antitoxin systems cooperate to induce persistence

Journal of the Royal Society Interface

Volumn 12, Issue 108, 2015, Pages

  Fasani, Rick A ^a   Savageau, Michael A ^a  

^a University of California Davis   (United States)

Author keywords

Bistability; Environment; Growth rate; Heterogeneous population; Multidrug tolerance; Stochastic noise

Indexed keywords

BACTERIA; CELLS; CYTOLOGY; GENE TRANSFER; GROWTH RATE; KINETIC PARAMETERS; KINETICS; OPTICAL BISTABILITY; POPULATION STATISTICS; STOCHASTIC SYSTEMS;

ENVIRONMENT; GROWING AND NON-GROWING CELLS; HETEROGENEOUS POPULATIONS; HORIZONTAL GENE TRANSFER; MULTIDRUG TOLERANCE; STOCHASTIC FLUCTUATION; STOCHASTIC NOISE; SWITCHING THRESHOLDS;

TOXIC MATERIALS;

ANTITOXIN; TOXIN; BACTERIAL PROTEIN;

ARTICLE; CHEMICAL INTERACTION; COUPLED SYSTEMS MODEL; CYTOARCHITECTURE; DEGRADATION KINETICS; GROWTH RATE; KINETIC PARAMETERS; NONHUMAN; PROTEIN SYNTHESIS; SINGLE SYSTEM MODEL; STEADY STATE; STOCHASTIC MODEL; TOXIN SYNTHESIS; VIRULENCE; BACTERIUM; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS);

BACTERIA; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MODELS, BIOLOGICAL;

EID: 84936758265     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2015.0130     Document Type: Article

References (74)

1. Bigger JW. 1944 Treatment of staphylococcal infections with penicillin by intermittent sterilisation. Lancet 244, 497-500. (doi:10.1016/S0140-6736(00)74210-3)
2. Lewis K. 2001 Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45, 999-1007. (doi:10.1128/AAC.45.4.999-1007.2001)
3. Potera C. 1999 Forging a link between biofilms and disease. Science 283, 1837-1839. (doi:10.1126/science.283.5409.1837)
4. National Institutes of Health. 1999 SBIR/STTR Study and Control of Microbial Biofilms. PA-99-084.
5. Mulcahy LR, Burns JL, Lory S, Lewis K. 2010 Emergence of Pseudomonas aeruginosa strains producing high levels of persister cells in patients with cystic fibrosis. J. Bacteriol. 192, 6191-6199. (doi:10.1128/JB.01651-09)
6. LaFleur MD, Qi Q, Lewis K. 2010 Patients with longterm oral carriage harbor high-persister mutants of Candida albicans. Antimicrob. Agents Chemother. 54, 39-44. (doi:10.1128/AAC.00860-09)
7. Fauvart M, De Groote VN, Michiels J. 2011 Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60, 699-709. (doi:10.1099/jmm.0. 030932-0)
8. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S. 2004 Bacterial persistence as a phenotypic switch. Science 305, 1622-1625. (doi:10.1126/science. 1099390)
9. Aldridge BB, Fernandez-Suarez M, Heller D, Ambravaneswaran V, Irimia D, Toner M, Fortune SM. 2012 Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility. Science 335, 100-104. (doi:10.1126/science. 1216166)
10. Orman MA, Brynildsen MP. 2013 Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57, 3230-3239. (doi:10.1128/AAC.00243-13)
11. Lewis K. 2010 Persister cells. Annu. Rev. Microbiol. 64, 357-372. (doi:10.1146/annurev.micro. 112408.134306)
12. Gerdes K, Maisonneuve E. 2012 Bacterial persistence and toxin antitoxin loci. Annu. Rev. Microbiol. 66, 103-123. (doi:10.1146/annurev-micro-092611-150159)
13. Christensen SK, Mikkelsen M, Pedersen K, Gerdes K. 2001 RelE, a global inhibitor of translation, is activated during nutritional stress. Proc. Natl Acad. Sci. USA 98, 14 328-14 333. (doi:10.1073/pnas. 251327898)
14. Pedersen K, Christensen SK, Gerdes K. 2002 Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins. Mol. Microbiol. 45, 501-510. (doi:10.1046/j.1365-2958.2002.03027.x)
15. Christensen SK, Pedersen K, Hansen FG, Gerdes K. 2003 Toxin-antitoxin loci as stress-responseelements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 332, 809-819. (doi:10.1016/S0022-2836(03) 00922-7)
16. Grady R, Hayes F. 2003 Axe-Txe, a broad-spectrum proteic toxin-antitoxin system specified by a multidrug-resistant, clinical isolate of Enterococcus faecium. Mol. Microbiol. 47, 1419-1432. (doi:10. 1046/j.1365-2958.2003.03387.x)
17. Zhang J, Zhang Y, Zhu L, Suzuki M, Inouye M. 2004 Interference of mRNA function by sequence-specific endoribonuclease PemK. J. Biol. Chem. 279, 20 678-20 684. (doi:10.1074/jbc.M314284200)
18. Korch SB, Hill TM. 2006 Ectopic overexpression of wild-type and mutant hipA genes in Escherichia coli: effects on macromolecular synthesis and persister formation. J. Bacteriol. 188, 3826-3836. (doi:10. 1128/JB.01740-05)
19. Liu M, Zhang Y, Inouye M, Woychik NA. 2008 Bacterial addiction module toxin Doc inhibits translation elongation through its association with the 30S ribosomal subunit. Proc. Natl Acad. Sci. USA 105, 5885-5890. (doi:10.1073/pnas.0711949105)
20. Falla TJ, Chopra I. 1998 Joint tolerance to b-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. Antimicrob. Agents Chemother. 42, 3282-3284.
21. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. 2004 Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186, 8172-8180. (doi:10.1128/JB.186. 24.8172-8180.2004)
22. Vázquez-Laslop N, Lee H, Neyfakh AA. 2006 Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol. 188, 3494-3497. (doi:10. 1128/JB.188.10.3494-3497.2006)
23. Shah D, Zhang Z, Khodursky A, Kaldalu N, Kurg K, Lewis K. 2006 Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6, 53. (doi:10.1186/1471-2180-6-53)
24. Moyed HS, Bertrand KP. 1983 hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155, 768-775.
25. Yamaguchi Y, Inouye M. 2011 Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat. Rev. Microbiol. 9, 779-790. (doi:10. 1038/nrmicro2651)
26. Ramage HR, Connolly LE, Cox JS. 2009 Comprehensive functional analysis of Mycobacterium tuberculosis toxinantitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet. 5, e1000767. (doi:10.1371/journal.pgen.1000767)
27. Van Melderen L, Saavedra De Bast M. 2009 Bacterial toxin-antitoxin systems: more than selfish entities? PLoS Genet. 5, e1000437. (doi:10.1371/journal. pgen.1000437)
28. Van Melderen L. 2010 Toxin-antitoxin systems: why so many, what for? Curr. Opin. Microbiol. 13, 781-785. (doi:10.1016/j.mib.2010.10.006)
29. Maisonneuve E, Shakespeare LJ, J?rgensen MG, Gerdes K. 2011 Bacterial persistence by RNA endonucleases. Proc. Natl Acad. Sci. USA 108, 13 206-13 211. (doi:10.1073/pnas.1100186108)
30. Fasani RA, Savageau MA. 2013 Molecular mechanisms of multiple toxin-antitoxin systems are coordinated to govern the persister phenotype. Proc. Natl Acad. Sci. USA 110, E2528-E2537. (doi:10. 1073/pnas.1301023110)
31. Dao-Thi M-H, Charlier D, Loris R, Maes D, Messens J, Wyns L, Backmann J. 2002 Intricate interactions within the ccd plasmid addiction system. J. Biol. Chem. 277, 3733-3742. (doi:10.1074/jbc. M105505200)
32. Lah J. 2005 Energetics of structural transitions of the addiction antitoxin MazE. J. Biol. Chem. 280, 17 397-17 407. (doi:10.1074/jbc.M501128200)
33. Cogan NG. 2007 Incorporating toxin hypothesis into a mathematical model of persister formation and dynamics. J. Theor. Biol. 248, 340-349. (doi:10. 1016/j.jtbi.2007.05.021)
34. Lou C, Li Z, Ouyang Q. 2008 A molecular model for persister in E. coli. J. Theor. Biol. 255, 205-209. (doi:10.1016/j.jtbi.2008.07.035)
35. Klumpp S, Zhang Z, Hwa T. 2009 Growth ratedependent global effects on gene expression in bacteria. Cell 139, 1366-1375. (doi:10.1016/j.cell. 2009.12.001)
36. Rotem E, Loinger A, Ronin I, Levin-Reisman I, Gabay C, Shoresh N, Biham O, Balaban NQ. 2010 Regulation of phenotypic variability by a thresholdbased mechanism underlies bacterial persistence. Proc. Natl Acad. Sci. USA 107, 12 541-12 546. (doi:10.1073/pnas.1004333107)
37. Dubnau D, Losick R. 2006 Bistability in bacteria. Mol. Microbiol. 61, 564-572. (doi:10.1111/j.1365-2958.2006.05249.x)
38. Savageau MA, Coelho PMBM, Fasani RA, Tolla DA, Salvador A. 2009 Phenotypes and tolerances in the design space of biochemical systems. Proc. Natl Acad. Sci. USA 106, 6435-6440. (doi:10.1073/pnas. 0809869106)
39. Gazit E, Sauer RT. 1999 Stability and DNA binding of the Phd protein of the phage P1 plasmid addiction system. J. Biol. Chem. 274, 2652-2657. (doi:10. 1074/jbc.274.5.2652)
40. Marianovsky I. 2000 The regulation of the Escherichia coli mazEF promoter involves an unusual alternating palindrome. J. Biol. Chem. 276, 5975-5984. (doi:10.1074/jbc.M008832200)
41. Madl T, Van Melderen L, Mine N, Respondek M, Oberer M, Keller W, Khatai L, Zangger K. 2006 Structural basis for nucleic acid and toxin recognition of the bacterial antitoxin CcdA. J. Mol. Biol. 364, 170-185. (doi:10.1016/j.jmb.2006.08.082)
42. Kędzierska B, Lian L-Y, Hayes F. 2007 Toxin-antitoxin regulation: bimodal interaction of YefM-YoeB with paired DNA palindromes exerts transcriptional autorepression. Nucleic Acids Res. 35, 325-339. (doi:10.1093/nar/gkl1028)
43. Monti MC, Hernández-Arriaga AM, Kamphuis MB, López-Villarejo J, Heck AJR, Boelens R, Díaz-Orejas R, van den Heuvel RHH. 2007 Interactions of Kid-Kis toxin-antitoxin complexes with the parD operator-promoter region of plasmid R1 are piloted by the Kis antitoxin and tuned by the stoichiometry of Kid-Kis oligomers. Nucleic Acids Res. 35, 1737-1749. (doi:10.1093/nar/gkm073)
44. Overgaard M, Borch J, J?rgensen MG, Gerdes K. 2008 Messenger RNA interferase RelE controls relBE transcription by conditional cooperativity. Mol. Microbiol. 69, 841-857. (doi:10.1111/j.1365-2958. 2008.06313.x)
45. Eldar A, Elowitz MB. 2010 Functional roles for noise in genetic circuits. Nature 467, 167-173. (doi:10. 1038/nature09326)
46. Hazan R, Sat B, Reches M, Engelberg-Kulka H. 2001 Postsegregational killing mediated by the P1 phage 'addiction module' phd-doc requires the Escherichia coli programmed cell death system mazEF. J. Bacteriol. 183, 2046-2050. (doi:10.1128/JB.183. 6.2046-2050.2001)
47. Garcia-Pino A, Christensen-Dalsgaard M, Wyns L, Yarmolinsky M, Magnuson RD, Gerdes K, Loris R. 2008 Doc of prophage P1 is inhibited by its antitoxin partner Phd through fold complementation. J. Biol. Chem. 283, 30 821-30 827. (doi:10.1074/jbc.M805654200)
48. Kasari V, Mets T, Tenson T, Kaldalu N. 2013 Transcriptional cross-activation between toxinantitoxin systems of Escherichia coli. BMC Microbiol. 13, 45. (doi:10.1186/1471-2180-13-45)
49. Hayes F, Van Melderen L. 2011 Toxins-antitoxins: diversity, evolution and function. Crit. Rev. Biochem. Mol. Biol. 46, 386-408. (doi:10.3109/10409238. 2011.600437)
50. Zhang Y, Inouye M. 2011 RatA (YfjG), an Escherichia coli toxin, inhibits 70S ribosome association to block translation initiation. Mol. Microbiol. 79, 1418-1429. (doi:10.1111/j.1365-2958.2010. 07506.x)
51. Zhang Y, Zhang J, Hoeflich KP, Ikura M, Qing G, Inouye M. 2003 MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol. Cell 12, 913-923. (doi:10. 1016/S1097-2765(03)00402-7)
52. Fasani RA, Savageau MA. 2010 Automated construction and analysis of the design space for biochemical systems. Bioinformatics 26, 2601-2609. (doi:10.1093/bioinformatics/btq479)
53. Schwartz R. 2008 Biological modeling and simulation: a survey of practical models, algorithms, and numerical methods. Cambridge, MA: MIT Press.
54. Coelho PMBM, Salvador A, Savageau MA. 2009 Quantifying global tolerance of biochemical systems: design implications for moiety-transfer cycles. PLoS Comp. Biol. 5, e1000319. (doi:10.1371/journal. pcbi.1000319)
55. Savageau MA, Fasani RA. 2009 Qualitatively distinct phenotypes in the design space of biochemical systems. FEBS Lett. 583, 3914-3922. (doi:10.1016/j.febslet.2009.10.073)
56. Tolla DA, Savageau MA. 2011 Phenotypic repertoire of the FNR regulatory network in Escherichia coli. Mol. Microbiol. 79, 149-165. (doi:10.1111/j.1365-2958.2010.07437.x)
57. Savageau MA. 2009 Biochemical systems analysis: a study of function and design in molecular biology, 40th anniversary edn. Charleston, SC: CreateSpace.
58. Cherny I, Gazit E. 2004 The YefM antitoxin defines a family of natively unfolded proteins. J. Biol. Chem. 279, 8252-8261. (doi:10.1074/jbc.M308263200)
59. Lehnherr H, Yarmolinsky MB. 1995 Addiction protein Phd of plasmid prophage P1 is a substrate of the ClpXP serine protease of Escherichia coli. Proc. Natl Acad. Sci. USA 92, 3274-3277. (doi:10.1073/pnas.92.8.3274)
60. Magnuson R, Yarmolinsky MB. 1998 Corepression of the P1 addiction operon by Phd and Doc. J. Bacteriol. 180, 6342-6351.
61. Garcia-Pino A, Balasubramanian S, Wyns L, Gazit E, De Greve H, Magnuson RD, Charlier D, van Nuland NAJ, Loris R. 2010 Allostery and intrinsic disorder mediate transcription regulation by conditional cooperativity. Cell 142, 101-111. (doi:10.1016/j. cell.2010.05.039)
62. Afif H, Allali N, Couturier M, Van Melderen L. 2001 The ratio between CcdA and CcdB modulates the transcriptional repression of the ccd poison-antidote system. Mol. Microbiol. 41, 73-82. (doi:10.1046/j.1365-2958.2001.02492.x)
63. Lah J, Marianovsky I, Glaser G, Engelberg-Kulka H, Kinne J, Wyns L, Loris R. 2003 Recognition of the intrinsically flexible addiction antidote MazE by a dromedary single domain antibody fragment. J. Biol. Chem. 278, 14 101-14 111. (doi:10.1074/jbc.M209855200)
64. Zhang J, Zhang Y, Inouye M. 2003 Characterization of the interactions within the mazEF addiction module of Escherichia coli. J. Biol. Chem. 278, 32 300-32 306. (doi:10.1074/jbc.M304767200)
65. Li G-Y, Zhang Y, Inouye M, Ikura M. 2008 Structural mechanism of transcriptional autorepression of the Escherichia coli RelB/RelE antitoxin/toxin module. J. Mol. Biol. 380, 107-119. (doi:10.1016/j.jmb. 2008.04.039)
66. Overgaard M, Borch J, Gerdes K. 2009 RelB and RelE of Escherichia coli form a tight complex that represses transcription via the ribbon-helix-helix motif in RelB. J. Mol. Biol. 394, 183-196. (doi:10. 1016/j.jmb.2009.09.006)
67. Ruiz-Echevarría MJ, de la Cueva G, Díaz-Orejas R. 1995 Translational coupling and limited degradation of a polycistronic messenger modulate differential gene expression in the parD stability system of plasmid R1. Mol. Gen. Genet. 248, 599-609. (doi:10.1007/BF02423456)
68. Li G-Y, Zhang Y, Chan MCY, Mal TK, Hoeflich KP, Inouye M, Ikura M. 2006 Characterization of dual substrate binding sites in the homodimeric structure of Escherichia coli mRNA interferase MazF. J. Mol. Biol. 357, 139-150. (doi:10.1016/j.jmb. 2005.12.035)
69. De Jonge N, Garcia-Pino A, Buts L, Haesaerts S, Charlier D, Zangger K, Wyns L, De Greve H, Loris R. 2009 Rejuvenation of CcdB-poisoned gyrase by an intrinsically disordered protein domain. Mol. Cell 35, 154-163. (doi:10.1016/j.molcel.2009.05.025)
70. Ray JCJ, Tabor JJ, Igoshin OA. 2011 Nontranscriptional regulatory processes shape transcriptional network dynamics. Nat. Rev. Microbiol. 9, 817-828. (doi:10.1038/nrmicro2667)
71. Dörr T, Vulić M, Lewis K. 2010 Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317. (doi:10. 1371/journal.pbio.1000317)
72. Vega NM, Allison KR, Khalil AS, Collins JJ. 2012 Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 8, 431-433. (doi:10.1038/nchembio.915)
73. Amato SM, Orman MA, Brynildsen MP. 2013 Metabolic control of persister formation in Escherichia coli. Mol. Cell 50, 475-487. (doi:10. 1016/j.molcel.2013.04.002)
74. Spoering AL, Lewis K. 2001 Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183, 6746-6751. (doi:10.1128/JB.183.23.6746-6751.2001)